Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition

Xilong Wang(Zhaotong University), Guixi Zheng(Qilu Hospital of Shandong University), Xiaoyu Zhang(University of Maryland, Baltimore), Na Zhao(Hainan Medical College Hospital), Xiaohan Li(Chongqing Medical University), Hongxing Wang(Zhoukou Normal University), Yi Zhang(Qilu Hospital of Shandong University), Xin Zhang(Wuhan University), Peng Su(Qilu Hospital of Shandong University), Zhipu Liu(Qilu Hospital of Shandong University)
The International Journal of Biochemistry & Cell Biology
March 7, 2024
Cited by 6


Related Papers